Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4 is a type I transmembrane glycoprotein primarily expressed on helper T cells, monocytes, macrophages, and dendritic cells. It functions as a co-receptor for the T cell receptor (TCR) during antigen recognition, binding to MHC class II molecules and initiating downstream signaling cascades that lead to T cell activation and differentiation. It is a key therapeutic target for HIV/AIDS and is implicated in various autoimmune diseases and cancers.
Co-receptor for TCR-MHC II interaction, amplifying downstream signaling through phosphorylation events.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell surface antigen CD4 (CD4).